GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales
"We expect another year of profitable growth in 2025, and have further improved our long-term outlook," said CEO Walmsley.
![GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales](https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-2173420062-e1738748622764.jpg?w=2048#)
Feb 6, 2025 0
Feb 6, 2025 0
Feb 6, 2025 0
Feb 6, 2025 0
Feb 6, 2025 0
Feb 6, 2025 0
Feb 6, 2025 0
Feb 6, 2025 0
Feb 6, 2025 0
Feb 6, 2025 0
Feb 6, 2025 0
Feb 6, 2025 0
Or register with email
Jan 27, 2025 0
Jan 28, 2025 0
Jan 28, 2025 0
Jan 28, 2025 0
Jan 29, 2025 0
Jan 30, 2025 1
Jan 29, 2025 0
Jan 28, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.